Fidelity Investments’s NRC Health Common Stock NRC Stock Holding History

Fidelity Investments’s Portfolio NRC Stock Details NRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$53K	Sell	2,456 -3	-0.1%	-$56	﹤0.01%	4282
2026 Q1	$41.8K	Buy	2,459 +1,115	+83%	+$18.9K	﹤0.01%	4205
2025 Q4	$25.2K	Sell	1,344 -11,973	-90%	-$181K	﹤0.01%	4379
2025 Q3	$170K	Sell	13,317 -11,998	-47%	-$180K	﹤0.01%	3433
2025 Q2	$425K	Buy	25,315 +18,641	+279%	+$252K	﹤0.01%	3018
2025 Q1	$85.4K	Sell	6,674 -4,145	-38%	-$66.5K	﹤0.01%	3626
2024 Q4	$191K	Buy	10,819 +7,875	+267%	+$149K	﹤0.01%	3291
2024 Q3	$67.3K	Buy	2,944 +2,352	+397%	+$53.1K	﹤0.01%	3659
2024 Q2	$13.6K	Buy	592 +39	+7%	+$1.2K	﹤0.01%	4217
2024 Q1	$21.9K	Sell	553 -22	-4%	-$870	﹤0.01%	3981
2023 Q4	$22.7K	Buy	575 +165	+40%	+$6.91K	﹤0.01%	3879
2023 Q3	$18.2K	Sell	410 -144	-26%	-$6.28K	﹤0.01%	3861
2023 Q2	$24.1K	Buy	554 +97	+21%	+$4.26K	﹤0.01%	3761
2023 Q1	$19.9K	Buy	457 +16	+4%	+$707	﹤0.01%	3846
2022 Q4	$16.5K	Sell	441 -78	-15%	-$3.02K	﹤0.01%	3848
2022 Q3	$21K	Buy	519 +164	+46%	+$6.07K	﹤0.01%	3834
2022 Q2	$14K	Sell	355 -127	-26%	-$4.59K	﹤0.01%	4001
2022 Q1	$20K	Sell	482 -480	-50%	-$18.8K	﹤0.01%	4019
2021 Q4	$40K	Hold	962	–	–	﹤0.01%	3289
2021 Q3	$40K	Buy	962 +212	+28%	+$10.7K	﹤0.01%	3265
2021 Q2	$35K	Sell	750 -1	-0.1%	-$48	﹤0.01%	3241
2021 Q1	$35K	Buy	751 +219	+41%	+$10.6K	﹤0.01%	3129
2020 Q4	$23K	Sell	532 -56	-10%	-$2.88K	﹤0.01%	3142
2020 Q3	$29K	Buy	588 +52	+10%	+$2.88K	﹤0.01%	2986
2020 Q2	$31K	Sell	536 -13	-2%	-$687	﹤0.01%	2893
2020 Q1	$26K	Sell	549 -27	-5%	-$1.62K	﹤0.01%	2897
2019 Q4	$38K	Buy	576 +297	+106%	+$18.2K	﹤0.01%	2963
2019 Q3	$16K	Sell	279 -79	-22%	-$4.9K	﹤0.01%	3121
2019 Q2	$21K	Buy	358 +261	+269%	+$12.1K	﹤0.01%	3060
2019 Q1	$4K	Buy	97 +41	+73%	+$1.61K	﹤0.01%	3313
2018 Q4	$2K	Hold	56	–	–	﹤0.01%	3331
2018 Q3	$2K	Buy	+56	New	+$2.12K	﹤0.01%	3397

Other funds holding NRC

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

WIC

Willis Investment Counsel Gainesville, Georgia $2.1B AUM 24.61% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return

FMII

Farmers & Merchants Investments Inc Lincoln, Nebraska $4.13B AUM 32.58% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Fidelity Investments's NRC Position: Q2 2026 in Review

Fidelity Investments reduced its NRC Health Common Stock (NRC) stake by 0.12% in Q2 2026, selling an estimated $56 and leaving 2,456 shares worth $53K. The position accounts for ﹤0.01% of the portfolio, ranked #4282.

Fidelity Investments first reported a position in NRC in Q3 2018 and has held it in 32 quarters since. The position peaked at $425K in Q2 2025. 123 funds tracked by Wall St. Rank hold NRC as of Q2 2026.

Fidelity Investments held 2,456 shares of NRC Health Common Stock worth $53K as of Q2 2026.
Fidelity Investments sold 3 NRC Health Common Stock shares in Q2 2026, an estimated $56.
NRC Health Common Stock made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #4282 holding.
Fidelity Investments first reported a position in NRC Health Common Stock in Q3 2018 and has held it in 32 quarters since.
Fidelity Investments's NRC Health Common Stock position peaked at $425K in Q2 2025.
123 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.